Treatment

Oral semaglutide clinical trials

Active studies that list Oral semaglutide as an intervention or treatment.

3active studies

2recruiting now

3countries represented

1largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 4

Type 2 Diabetes Mellitus (T2DM)Condition

Oral semaglutide, Empagliflozin 10 mgTreatment

Slovenia1 locations

University Medical Centre LjubljanaSponsor

Updated 2026-04-30 · NCT06613854See eligibility →

Recruiting nowPhase 4

Primary Open Angle Glaucoma (POAG), Open-Angle GlaucomaCondition

Oral semaglutide, PlaceboTreatment

Denmark1 locations

Glostrup University Hospital, CopenhagenSponsor

Updated 2025-01-24 · NCT06792422See eligibility →

Active, not recruitingNot applicable

Type 2 Diabetes, Heart FailureCondition

Oral semaglutide, SitagliptinTreatment

United States1 locations

Brigham and Women's HospitalSponsor

Updated 2026-07-01 · NCT07390110See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.